GHASSAN ABOU-ALFA, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Arcus, Agios, Astra Zeneca, BioNtech, BMS, Celgene, Flatiron, Genentech/Roche, Genoscience, Incyte, Polaris, Puma, QED, Silenseed, Yiviva
    Topic:
    Research support to institution
    Date added:
    12/08/2021
    Date updated:
    12/08/2021
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Adicet, Alnylam, Astra Zeneca, Autem, Bayer, Beigene, Berry Genomics, Eisai, Exelixis, Flatiron, Genentech/Roche, Genoscience, Helio, Incyte, Ipsen, Legend Biotech, Merck, Nerviano, QED, Redhill, Servier, Surface Oncology, Therabionics, Vector, Yiviva
    Topic:
    Consulting
    Date added:
    12/08/2021
    Date updated:
    12/08/2021
    Relationship end date:
    12/31/2022
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca, Celgene, Cend, CytomX, Eli Lilly, Merck, Rafael, Silenseed, Sobi
    Topic:
    Consulting
    Date added:
    12/08/2021
    Date updated:
    12/08/2021
    Relationship end date:
    12/31/2022
Return to 2022 Summit on Cancer Health Disparities